Ligand validation:3LKJ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3LKJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3LKJ_NAG_A_2	50%	29%	0.157	0.907	0.53	2.24	-	6	1	0	100%	0.9333
3LKJ_NAG_C_2	42%	25%	0.161	0.88	0.44	2.57	-	4	3	1	100%	0.9333
3LKJ_NAG_B_2	30%	40%	0.22	0.886	0.89	1.44	1	2	3	0	100%	0.9333
3LKJ_NAG_A_3	24%	30%	0.224	0.867	0.65	2.12	-	4	0	0	93%	0.9333
3LKJ_NAG_C_3	21%	30%	0.205	0.823	0.6	2.15	-	5	2	0	93%	0.9333
3LKJ_NAG_B_3	3%	56%	0.286	0.635	0.54	1.15	-	2	3	0	93%	0.9333
3QD6_NAG_B_1411	42%	60%	0.165	0.882	0.78	0.75	1	-	2	0	100%	0.9333
7SGM_NAG_C_301	24%	27%	0.211	0.841	0.82	2.1	-	3	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.